Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesGuidelines - Diabetes
MIMS summaries
At-a-glance summaries of authoritative evidence-based clinical guidelines on diabetes, prepared by the MIMS editorial team.
Management of Type 2 Diabetes (NICE Guideline)
Summary of NICE guidance on treatment of type 2 diabetes.
Current Medical Standards of Fitness to Drive (DVLA Guidance)
Key advice from DVLA on fitness to drive.
NICE technology appraisals
Decisions by the National Institute for Health and Care Excellence on NHS access to diabetes treatments.
-
Dapagliflozin in Triple Therapy for Treating Type 2 Diabetes (TA418)
-
Canagliflozin, Dapagliflozin and Empagliflozin as Monotherapies for Treating Type 2 Diabetes (TA390)
-
Aflibercept for Treating Diabetic Macular Oedema (TA346)
-
Empagliflozin in Combination Therapy for Treating Type 2 Diabetes (TA336)
-
Canagliflozin in Combination Therapy for Treating Type 2 Diabetes (TA315)
-
Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes (TA288)
-
Exenatide Prolonged-Release Suspension for Injection in Combination with Oral Antidiabetic Therapy for the Treatment of Type 2 Diabetes (TA248)
-
Diabetes: Continuous Subcutaneous Insulin Infusion - Update (NICE)
-
Diabetes: Long-Acting Insulin Analogues (Insulin Glargine) (NICE)
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
